(R) -Levrazoxane
(R) -Levrazoxane ((R) -ICRF 186) is enzymatically hydrolysed to one-ring open intermediates by dihydropyrimidine amidohydrolase (DPHase), which is present in the liver and kidney. The radiosensitizing efficiency of (R) -Levrazoxane towards EMT6 mouse mammary tumour cells is greater than that of Dexrazoxane (HY-B0581) . (R) -Levrazoxane is promising for research of liver and kidney related diseases[1].
Product Specifications
CAS Number
[24613-06-7]
Product Name Alternative
(R) -ICRF 186
UNSPSC
12352005
Hazard Statement
H302+H312+H332-H315-H319
Target
Drug Intermediate
Type
Reference compound
Related Pathways
Others
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/r-levrazoxane.html
Smiles
C[C@H](CN(CC(N1)=O)CC1=O)N(CC(N2)=O)CC2=O
Molecular Formula
C11H16N4O4
Molecular Weight
268.27
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Archaemetzincin 2 (AMZ2) (NM_001033572) Human Tagged ORF Clone Lentiviral Particle
CBP, p300 (CREB Binding Protein, Histone Acetyl Transferase, RTS, RSTS, Rubinstein-Taybi Syndrome) (BSA & Azide Free) (Biotin)
CBP, p300 (CREB Binding Protein, Histone Acetyl Transferase, RTS, RSTS, Rubinstein-Taybi Syndrome) (BSA & Azide Free) (Biotin)